{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:22:49Z","timestamp":1761582169103},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12185-022-03306-y","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T10:10:00Z","timestamp":1644833400000},"page":"139-145","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic active Epstein\u2013Barr virus infection presenting as refractory chronic sinusitis"],"prefix":"10.1007","volume":"116","author":[{"given":"Wataru","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Toji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisakazu","family":"Nishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuharu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"3306_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673\u201386.","journal-title":"Blood"},{"key":"3306_CR2","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, et al. Characterization and treatment of chronic active Epstein\u2013Barr virus disease: a 28-year experience in the United States. Blood. 2011;117:5835\u201349.","journal-title":"Blood"},{"key":"3306_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome KI, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, et al. Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection: a retrospective analysis. Int J Hematol. 2011;93:602\u20139.","journal-title":"Int J Hematol"},{"key":"3306_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","volume":"103","author":"K Kawamoto","year":"2018","unstructured":"Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, et al. A distinct subtype of Epstein\u2013Barr virus-positive t\/nk-cell lymphoproliferative disorder: Adult patients with chronic active Epstein\u2013Barr virus infection-like features. Haematologica. 2018;103:1018\u201328.","journal-title":"Haematologica"},{"key":"3306_CR5","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","volume":"4","author":"I Yonese","year":"2020","unstructured":"Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020;4:2918\u201326.","journal-title":"Blood Adv"},{"key":"3306_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201367.","journal-title":"J Clin Oncol"},{"key":"3306_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17:389\u2013400.","journal-title":"Lancet Oncol"},{"key":"3306_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","volume":"35","author":"M Yamaguchi","year":"2017","unstructured":"Yamaguchi M, Suzuki R, Oguchi M, Asano N, Amaki J, Akiba T, et al. Treatments and outcomes of patients with extranodal natural killer\/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan. J Clin Oncol. 2017;35:32\u20139.","journal-title":"J Clin Oncol"},{"key":"3306_CR9","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","volume":"98","author":"YYA Kasahara","year":"2001","unstructured":"Kasahara YYA, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S. Differential cellular targets of Epstein\u2013Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001;98:1882\u20138.","journal-title":"Blood"},{"key":"3306_CR10","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1128\/JVI.76.21.11139-11142.2002","volume":"76","author":"P Trempat","year":"2002","unstructured":"Trempat P, Tabiasco J, Andre P, Faumont N, Meggetto F, Delsol G, et al. Evidence for early infection of nonneoplastic natural killer cells by Epstein\u2013Barr virus. J Virol. 2002;76:11139\u201342.","journal-title":"J Virol"},{"key":"3306_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/rmv.505","volume":"16","author":"H Kimura","year":"2006","unstructured":"Kimura H. Pathogenesis of chronic active Epstein\u2013Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16:251\u201361.","journal-title":"Rev Med Virol"},{"key":"3306_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen JI. Chronic active Epstein\u2013Barr virus disease. Front Immunol. 2017;8:1\u20136.","journal-title":"Front Immunol"},{"key":"3306_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/ped.12892","volume":"58","author":"M Shimomura","year":"2016","unstructured":"Shimomura M, Morishita H, Meguro T, Seto S, Kimura M, Hamazaki M. Chronic active EBV infection with features of granulomatosis with polyangiitis. Pediatr Int. 2016;58:639\u201342.","journal-title":"Pediatr Int"},{"key":"3306_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-3-319-74835-1_13","volume":"96","author":"AR Sedaghat","year":"2018","unstructured":"Sedaghat AR. Chronic rhinosinusitis. Infect Ears Nose Throat Sinuses. 2018;96:155\u201368.","journal-title":"Infect Ears Nose Throat Sinuses"},{"key":"3306_CR15","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2169\/internalmedicine.4127-19","volume":"59","author":"M Ueno","year":"2020","unstructured":"Ueno M, Nakano K, Miyagawa I, Tanaka Y. Five cases of IgG4-related disease with nasal mucosa and sinus involvement. Intern Med. 2020;59:1905\u201311.","journal-title":"Intern Med"},{"key":"3306_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/15513815.2012.659385","volume":"31","author":"W Liu","year":"2012","unstructured":"Liu W, Ren J, Shu Q. Aggressive sinonasal natural killer\/T-cell lymphoma mimicking refractory sinusitis in a 4-year-old boy. Fetal Pediatr Pathol. 2012;31:288\u201394.","journal-title":"Fetal Pediatr Pathol"},{"key":"3306_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-2559.2011.03976.x","volume":"59","author":"E Takahashi","year":"2011","unstructured":"Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, et al. Clinicopathological analysis of the age-related differences in patients with Epstein\u2013Barr virus (EBV)-associated extranasal natural killer (NK)\/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Histopathology. 2011;59:660\u201371.","journal-title":"Histopathology"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03306-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03306-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03306-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T17:00:55Z","timestamp":1656003655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03306-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["3306"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03306-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"31 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}